Gefitero 250mg Tablets: Product Information, Benefits, Side Effects and FAQs

Gefitero 250mg Tablets contain gefitinib 250 mg, a targeted anticancer medicine belonging to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Gefitinib is used under specialist supervision to treat certain patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have specific activating EGFR mutations.

For healthcare professionals and pharmaceutical procurement teams in Singapore, accurate product information is essential when evaluating oncology medicines. Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information to support informed business enquiries, subject to applicable regulatory and supply requirements.

Active Ingredient: Gefitinib 250 mg

Dosage Form: Tablet

Therapeutic Category: Targeted anticancer medicine

Intended Use: Specific forms of EGFR-mutated non-small cell lung cancer, as determined by an oncology specialist.

Product registration, manufacturer details, packaging and availability should be independently verified for the exact product before procurement.

Medical Uses and Potential Benefits of Gefitero 250mg

Gefitinib works by inhibiting EGFR tyrosine kinase, a protein involved in cellular growth and signalling. In cancers with susceptible EGFR mutations, this action can help slow or inhibit tumour growth.

Potential clinical benefits in appropriately selected patients include:

Targeted treatment: Acts on EGFR signalling involved in the growth of certain lung cancer cells.

Treatment of eligible NSCLC: May help control disease in patients whose tumours have the relevant EGFR mutations.

Oral administration: Available as a tablet, allowing treatment outside a hospital when considered appropriate by the treating specialist.

Individualised cancer care: Treatment response and tolerability can be monitored by an oncology team.

Treatment outcomes vary according to tumour characteristics, previous treatments and individual patient factors. Gefitinib is not suitable for every person with lung cancer and should not be used without a specialist's prescription.

Gefitero 250mg Side Effects

Like other targeted cancer medicines, gefitinib can cause side effects. Commonly reported effects include:

Diarrhoea

Acne-like skin rash

Dry skin

Nausea and reduced appetite

Fatigue or weakness

Mouth irritation or sores

Nail and eye-related problems

Important safety warning: Seek urgent medical assessment for new or worsening breathlessness, cough or fever, severe or persistent diarrhoea, significant eye pain or vision changes, yellowing of the skin or eyes, or a severe blistering rash. These symptoms may indicate serious complications.

Patients should inform their doctor about existing medical conditions, pregnancy or breastfeeding, and all medicines or supplements they use. Do not change or discontinue treatment without medical advice unless emergency care is required.

Frequently Asked Questions (FAQs)

1. What is Gefitero 250mg used for?

Gefitero contains gefitinib and is used for certain cases of EGFR-mutated non-small cell lung cancer under specialist supervision.

2. What is the active ingredient in Gefitero 250mg Tablets?

The active ingredient is gefitinib, at a strength of 250 mg per tablet.

3. How should Gefitero 250mg be taken?

Follow the exact dosage and administration instructions prescribed by the treating oncologist. Do not adjust the dose independently.

4. What are the common side effects of Gefitero?

Common effects include diarrhoea, skin rash, dry skin, nausea, appetite changes and fatigue. Serious symptoms require prompt medical attention.

5. Is Gefitero 250mg available in Singapore?

Availability and registration of the exact brand must be confirmed through Singapore's Health Sciences Authority (HSA) resources and authorised pharmaceutical supply channels.

6. How can healthcare professionals enquire about this product?

Healthcare professionals and eligible pharmaceutical procurement organisations may contact Cordium Pharmaceuticals Pvt. Ltd. to request product documentation, subject to applicable regulatory requirements.

Pharmaceutical Product Enquiries | Cordium Pharmaceuticals Pvt. Ltd.

For product documentation or pharmaceutical trade enquiries concerning Gefitero 250mg Tablets, contact Cordium Pharmaceuticals Pvt. Ltd. to discuss product specifications, manufacturer information and applicable export requirements.